Selection of Vaccinia Virus Recombinants Using CRISPR/Cas9.

Gowripalan, Anjali; Smith, Stewart A; Tscharke, David C

Gowripalan, Anjali; Smith, Stewart A; Tscharke, David C.

Afiliación

Gowripalan A; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Smith SA; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Tscharke DC; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.

Bio Protoc ; 11(24): e4270, 2021 Dec 20.

Article en En | MEDLINE | ID: mdl-35087929

Palabras clave

CRISPR/Cas9 selection; Recombinant virus; VACV; Vaccine development; Vaccinia virus; Virotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Bio Protoc Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google